Diabetes, Metabolic, Endocrine

We focus on ensuring appropriate endpoints are met including glycaemic control, insulin management, and enhanced hormonal management.

Clinical trials in diabetes, metabolic disorders, and endocrinology play a vital role in advancing our understanding of these conditions and improving patient care. 

Common indications we have experience in include:
  • Type 1 and Type 2 Diabetes Mellitus
  • Obesity and Metabolic Syndrome
  • Thyroid and Adrenal Disorders
  • Hormone Replacement Therapy (HRT)

Disciplined,

Cost-Efficient Execution

while maintaining the Highest Quality

Local Trials,

Global Approvals

Access FDA Regulatory Expertise

Our Clinical Team has over

120

years

of Combined Clinical Trial Experience

Addressing Common Pain Points Associated with Diabetes, Metabolic & Endocrine Clinical Trials 

Diabetes, metabolic, and endocrine disorders are heterogeneous in their progression. The variable disease patterns can affect the consistency of study results.

iNGENū CRO addresses this pain point with Tailored Patient Segmentation

iNGENū employs stratified patient selection, ensuring participants have a similar disease progression stage, providing more consistent results.

Dietary habits, exercise routines, and other lifestyle factors play significant roles in these conditions, making it challenging to maintain consistency across participants.

iNGENū addresses this pain point with Dietary and Lifestyle Standardisation

We collaborate with nutritionists and lifestyle experts to create standardised guidelines for participants during the trial. This reduces variability and ensures consistency in external influences.

Given the chronic nature of these conditions, trials often require long-term monitoring, which can lead to attrition and inconsistencies in treatment adherence.

iNGENū addresses this pain point with Long-Term Support and Engagement Platforms

We have developed a comprehensive patient support platform, specifically for diabetes and endocrine patients, that includes regular check-ins, reminders, and educational resources to boost long-term compliance.

Endocrine trials face challenges with hormonal fluctuations in participants, which can influence study outcomes.

iNGENū addresses this pain point with Hormone Monitoring Protocols

Our trials in the endocrine space include rigorous hormonal monitoring, using advanced hormonal assays to account for and manage hormonal fluctuations, ensuring that they don't interfere with trial outcomes.

Many patients with these disorders are on multiple medications. Interactions between study drugs and existing medications can pose safety concerns and skew results.

iNGENū addresses this pain point with Detailed Medication Review

Before enrolment, we conduct a thorough review of a participant's medication regimen. This not only helps in selecting the right participants but also in predicting and monitoring potential drug interactions.

Diabetes, Metabolic & Endocrine Clinical Trial Resources

iNGENu CRO - Hypercholesterolemia-1

Hypercholesterolemia 

Explore diagnostic criteria, epidemiology, pivotal endpoints, and the challenges of endpoint determination.

Read our whitepaper
iNGENu CRO - Obesity

Obesity

Navigating the complex landscape of Obesity Clinical Trials, including pivotal endpoints, and enhance protocols.

Read our whitepaper

The iNGENū CRO Difference

iNGENu - FDA
Local Trials, Global Approvals

We uniquely combine Australian expertise with direct FDA submission capabilities, offering a streamlined path for sponsors to achieve global approval. Our seamless integration allows trial data from Australia to be submitted directly to the FDA via our E-Gateway, eliminating the need for third-party intermediaries.

iNGENu - cost efficient
Disciplined, Cost-Efficient Execution

iNGENū CRO takes a highly strategic and disciplined approach to clinical research, ensuring that every dollar is directed toward generating meaningful outcomes. Our trials are designed with efficiency in mind, eliminating unnecessary costs while maintaining the highest scientific and regulatory standards.

iNGENu - APAC
Australian-Headquartered, Asia-Pacific Reach

We provide sponsors with comprehensive trial capabilities across the Asia-Pacific region, offering a seamless combination of cost-efficiency and high-quality clinical trials. We leverage the region's competitive pricing while maintaining rigorous Australian-based project management and clinical oversight.

"We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have used iNGENū for: Medical writing, project management, clinical data management and full end-to-end, clinical trial execution and monitoring.

We have been very happy with all aspects of the management of the clinical trial and have been particularly impressed by the out-of-the-box creative solutions to speed up and reduce overheads for our company during this clinical trial."

Giles Moss
Chief Executive Officer

iNGENu testimonial-logos-monotone-1
Ready to discuss your trial?